Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS Rose Ball promises to be an unforgettable experience
2005-09-08

On Saturday 15 of October 2005, the Department of Paediatrics and Child Health at the University of the Free State (UFS) in collaboration with Medi-Clinic, are hosting a Rose Ball in aid of children and babies with serious diseases and special needs.

The Bloemfontein public should get ready for one of the most magnificent events ever held in the city. 

The Rose Ball promises to offer an evening of glamour, elegance and beauty which will make it an unforgettable and unique event.  The Department aims to make the Rose Ball an annual event to which the Bloemfontein public can look forward to with expectation.

“Excellent food and wine, a 35 man symphony orchestra and of course a magical setting awaits those who attend the Rose Ball.  We will do everything possible to make guests feel special, so that they return to the Rose Ball year after year.  In this way, we can ensure an annual income from this event for children and babies who are very ill and need specialised care,” said Prof. André Venter, Head of the Department of Paediatrics and Child Health.

The Department of Paediatrics and Child Health at the UFS is responsible for the tertiary care, that is highly specialised care, of around 1 000 000 children in the Free State, Northern Cape, North-West, Eastern Cape and Lesotho.  Approximately 13 000 out-patients are treated at the Universitas and Pelonomi Hospitals annually.  Children who suffer from cancer, heart disease, neurological disease and endocrinological and gastro-enterological conditions are treated.  The Department is also responsible for children who need intensive care and children with contagious diseases.  In addition, there is a large neonatal unit where prematurely born babies are treated.

The level of health care needed to treat these children and babies, necessitate highly specialised equipment and knowledge.  However, it is not always possible to replace or upgrade equipment, due to the lack of much-needed funds.  That is why a fund was created within the Department to satisfy the need for funds. The Rose Ball promises to eventually give a vital boost to the fund that will go a long way toward providing in the special healthcare needs of these patients.

The Rose Ball is made possible thanks to the support of Medi-Clinic.

“Medi-Clinic is honoured to be involved in this great effort and in this way take hands with the Department of Paediatrics and Child Health at the UFS.  There are so many children with life-threatening diseases today and we cannot afford to be uninvolved in any effort to make life better and easier for these children.  We at Medi-Clinic, as a private sector company, look forward to establishing a long-term commitment with the Department of Paediatrics and Child Health,” said Mr Sakkie van der Merwe, Hospital Manager of Bloemfontein Medi-Clinic.

Only a limited number of tables are still available for the Rose Ball.  Tickets cost R500 per person or R5 000 per table of 10 people. 

Those who are interested can contact Ms Ilse Olivier at 051-4012415 or Ms Adele van Aswegen at 051-4013535 for more information.

Media release
Issued by:  Lacea Loader
   Media Representative
   Tel:  (051) 401-2584
   Cell:  083 645 2454
   E-mail:  loaderl.stg@mail.uovs.ac.za
8 September 2005
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept